| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
|
J Clin Endocrinol Metab
|
2005
|
4.39
|
|
2
|
Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis.
|
World J Surg Oncol
|
2004
|
2.33
|
|
3
|
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.
|
Cancer Res
|
2010
|
2.15
|
|
4
|
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
|
Proc Natl Acad Sci U S A
|
2013
|
2.02
|
|
5
|
Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis.
|
Mod Pathol
|
2006
|
1.87
|
|
6
|
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas.
|
Int J Gynecol Pathol
|
2012
|
1.55
|
|
7
|
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
|
Gynecol Oncol
|
2005
|
1.40
|
|
8
|
Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification.
|
J Clin Pathol
|
2013
|
1.37
|
|
9
|
MicroRNA signatures differentiate uterine cancer tumor subtypes.
|
Gynecol Oncol
|
2010
|
1.29
|
|
10
|
Identification of binding sites of EVI1 in mammalian cells.
|
J Biol Chem
|
2005
|
1.16
|
|
11
|
Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer.
|
J Oncol
|
2011
|
1.15
|
|
12
|
Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
|
Am J Pathol
|
2002
|
1.08
|
|
13
|
Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement.
|
Mod Pathol
|
2006
|
1.08
|
|
14
|
Isolated noncompaction of the ventricular myocardium: clinical and molecular aspects of a rare cardiomyopathy.
|
Lab Invest
|
2002
|
1.07
|
|
15
|
Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases.
|
Am J Surg Pathol
|
2008
|
1.07
|
|
16
|
Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice.
|
Mod Pathol
|
2013
|
1.05
|
|
17
|
Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).
|
Mol Cancer Ther
|
2010
|
1.03
|
|
18
|
STAT3-mediated signaling in the determination of rod photoreceptor cell fate in mouse retina.
|
Invest Ophthalmol Vis Sci
|
2004
|
1.02
|
|
19
|
Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
|
Int J Clin Exp Pathol
|
2013
|
1.01
|
|
20
|
BRAF mutation testing in clinical practice.
|
Expert Rev Mol Diagn
|
2012
|
1.00
|
|
21
|
Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis.
|
Thyroid
|
2013
|
0.99
|
|
22
|
Multiple angiomyolipomata of the liver: a case report.
|
Mod Pathol
|
2002
|
0.97
|
|
23
|
BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation.
|
Mod Pathol
|
2012
|
0.93
|
|
24
|
HER-2/NEU overexpression in vulvar Paget disease: the Yale experience.
|
J Clin Pathol
|
2010
|
0.93
|
|
25
|
T-DM1, a novel antibody-drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo.
|
Cancer Med
|
2014
|
0.90
|
|
26
|
Hormonal therapy for aggressive angiomyxoma: a case report and proposed management algorithm.
|
J Low Genit Tract Dis
|
2014
|
0.89
|
|
27
|
Atypical angiomyolipoma of kidney in a patient with tuberous sclerosis: a case report with p53 gene mutation analysis.
|
Arch Pathol Lab Med
|
2005
|
0.88
|
|
28
|
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.
|
Int J Gynecol Cancer
|
2014
|
0.88
|
|
29
|
Lack of genetic association between exaggerated placental site reaction and placental site trophoblastic tumor.
|
Int J Gynecol Pathol
|
2008
|
0.88
|
|
30
|
BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
|
Acta Cytol
|
2011
|
0.87
|
|
31
|
Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.
|
Thyroid
|
2011
|
0.87
|
|
32
|
Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma.
|
Am J Clin Pathol
|
2007
|
0.87
|
|
33
|
Comparison of Affirm VPIII and Papanicolaou tests in the detection of infectious vaginitis.
|
Am J Clin Pathol
|
2011
|
0.87
|
|
34
|
High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.
|
Reprod Sci
|
2012
|
0.86
|
|
35
|
High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger.
|
Int J Clin Exp Pathol
|
2008
|
0.86
|
|
36
|
Glial heterotopia of the uterine cervix: DNA genotyping confirmation of its fetal origin.
|
Int J Gynecol Pathol
|
2010
|
0.86
|
|
37
|
Precise DNA genotyping diagnosis of hydatidiform mole.
|
Obstet Gynecol
|
2010
|
0.85
|
|
38
|
Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis.
|
Am J Surg Pathol
|
2008
|
0.85
|
|
39
|
Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
|
Cancer Cytopathol
|
2013
|
0.85
|
|
40
|
Partial hydatidiform mole: histologic parameters in correlation with DNA genotyping.
|
Int J Gynecol Pathol
|
2013
|
0.84
|
|
41
|
Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct.
|
Histopathology
|
2012
|
0.83
|
|
42
|
Expression of glypican 3 in placental site trophoblastic tumor.
|
Diagn Pathol
|
2010
|
0.83
|
|
43
|
Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma.
|
Am J Clin Pathol
|
2009
|
0.81
|
|
44
|
Deparaffinization and lysis by hydrothermal pressure (pressure cooking) coupled with chaotropic salt column purification: a rapid and efficient method of DNA extraction from formalin-fixed paraffin-embedded tissue.
|
Diagn Mol Pathol
|
2013
|
0.81
|
|
45
|
Expression of CD56 and WT1 in ovarian stroma and ovarian stromal tumors.
|
Am J Surg Pathol
|
2008
|
0.79
|
|
46
|
Absence of human herpesvirus 8 in pemphigus and bullous pemphigoid.
|
Int J Clin Exp Pathol
|
2009
|
0.79
|
|
47
|
Intravenous leiomyomatosis revisited: an experience of 14 cases at a single medical center.
|
Int J Gynecol Pathol
|
2015
|
0.79
|
|
48
|
Marked heterogeneity of HER2/NEU gene amplification in endometrial serous carcinoma.
|
Genes Chromosomes Cancer
|
2013
|
0.79
|
|
49
|
Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions.
|
Cancer Cytopathol
|
2011
|
0.79
|
|
50
|
Minimal uterine serous carcinoma with extrauterine tumor of identical morphology: an immunohistochemical study of 13 cases.
|
Appl Immunohistochem Mol Morphol
|
2010
|
0.79
|
|
51
|
T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2.
|
Clin Exp Metastasis
|
2014
|
0.78
|
|
52
|
Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping.
|
Mod Pathol
|
2008
|
0.78
|
|
53
|
KRAS mutations are associated with specific morphologic features in colon cancer.
|
J Clin Gastroenterol
|
2013
|
0.78
|
|
54
|
A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria.
|
Arch Pathol Lab Med
|
2013
|
0.78
|
|
55
|
Molecular pathology as the driving force for personalized oncology.
|
Expert Rev Mol Diagn
|
2012
|
0.78
|
|
56
|
A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
|
Arch Pathol Lab Med
|
2016
|
0.78
|
|
57
|
Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
|
Am J Dermatopathol
|
2004
|
0.77
|
|
58
|
KRAS mutation testing in clinical practice.
|
Expert Rev Mol Diagn
|
2014
|
0.77
|
|
59
|
Pulmonary atresia with intact ventricular septum (PA-IVS) in monozygotic twins.
|
Am J Med Genet A
|
2008
|
0.77
|
|
60
|
Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression.
|
J Oncol
|
2011
|
0.77
|
|
61
|
Cancerous 'floater': a lesson learned about tissue identity testing, endometrial cancer and microsatellite instability.
|
Mod Pathol
|
2013
|
0.76
|
|
62
|
HER-2/neu receptor gene status in endometrial carcinomas: a tissue microarray study.
|
Histopathology
|
2010
|
0.76
|
|
63
|
CSF IgH gene rearrangement analysis in isolated post-transplant lymphoproliferative disorder of the central nervous system.
|
J Neurooncol
|
2007
|
0.76
|
|
64
|
Composite peripheral T-cell lymphoma not otherwise specified, and B-cell small lymphocytic lymphoma presenting with hemophagocytic lymphohistiocytosis.
|
Int J Surg Pathol
|
2012
|
0.75
|
|
65
|
Correction: Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis.
|
World J Surg Oncol
|
2005
|
0.75
|
|
66
|
[Diagnosis, histopathologic grading and prognostic moleculer marker analysis in patients with pancreatic neuroendocrine neoplasm].
|
Zhonghua Bing Li Xue Za Zhi
|
2013
|
0.75
|
|
67
|
Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
|
Int J Gynecol Pathol
|
2017
|
0.75
|
|
68
|
Genotyping diagnosis of nongestational choriocarcinoma involving fallopian tube and broad ligament: a case study.
|
Int J Gynecol Pathol
|
2014
|
0.75
|
|
69
|
[Pathogenesis of endometrial cancer: clinicopathologic implications].
|
Zhonghua Bing Li Xue Za Zhi
|
2006
|
0.75
|
|
70
|
[Molecular diagnosis of molar pregnancy].
|
Zhonghua Bing Li Xue Za Zhi
|
2011
|
0.75
|
|
71
|
Diagnostic value of K-ras mutation analysis for pancreaticobiliary cytology specimens with indeterminate diagnosis.
|
Cancer Cytopathol
|
2012
|
0.75
|
|
72
|
Comparing two methods of detection for Chlamydia trachomatis in liquid-based Papanicolaou tests.
|
Am J Clin Pathol
|
2012
|
0.75
|
|
73
|
FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
|
Int J Gynecol Pathol
|
2017
|
0.75
|
|
74
|
Egg donor pregnancy: a potential pitfall in DNA genotyping diagnosis of hydatidiform moles.
|
Int J Gynecol Pathol
|
2014
|
0.75
|
|
75
|
Comprehensive Analysis of PAX8 Expression in Epithelial Malignancies of the Uterine Cervix.
|
Int J Gynecol Pathol
|
2017
|
0.75
|
|
76
|
Primary or secondary? Genotyping confirmation of an ovarian primary carcinoid tumor.
|
Int J Gynecol Pathol
|
2008
|
0.75
|
|
77
|
Anaplastic oligoastrocytoma in Turcot syndrome.
|
J Neurooncol
|
2009
|
0.75
|
|
78
|
Craniopharyngioma arising in a Rathke's cleft cyst: case report.
|
J Neurosurg Pediatr
|
2015
|
0.75
|
|
79
|
Human herpesvirus-8 is not associated with angiolymphoid hyperplasia with eosinophilia.
|
J Cutan Pathol
|
2004
|
0.75
|
|
80
|
Mitotically active microglandular hyperplasia of the cervix: a case series with implications for the differential diagnosis.
|
Int J Gynecol Pathol
|
2014
|
0.75
|